Physician
Internal Medicine
Joshua Dilworth
|
|
Give Review
Joshua Dilworth is an expert in the field of Internal Medicine. Joshua Dilworth is a published doctor as well. He has 6 publications published. The latest was: Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Adaptive Image-guided Radiotherapy (IGRT) Eliminates the Risk of Biochemical Failure Caused by the Bias of Rectal Distension in Prostate Cancer Treatment Planning: Cli...
- Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.
- The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma ce...
- Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
- Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.
Schools
Wayne State University
Doctors Specialties
- Radiation Oncology
- Internal Medicine
Accepted Insurances
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497910285 |
| Last Name Of The Provider | DILWORTH |
| First Name Of The Provider | JOSHUA |
| View All |
Similar Doctors
|
|
Dr. Estela E. Mogrovejo, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jill E. Gualdoni, MD |
|
|
Dr. Larry L. Kestin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neha P. Amin, MD |
|
|
Dr. Kuei C. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica L. Wobb, MD |